Literature DB >> 30379360

Motor cortical excitability during voluntary inhibition of involuntary tic movements.

Christos Ganos1,2,3, Lorenzo Rocchi3, Anna Latorre3,4, Leanne Hockey3, Clare Palmer3, Eileen M Joyce3, Kailash P Bhatia3, Patrick Haggard2, John Rothwell3.   

Abstract

BACKGROUND: Tics can be voluntarily inhibited. However, the neurophysiology of voluntary tic inhibition remains underexplored. The objective of this study was to explore state-dependent effects of voluntary tic inhibition on M1 excitability.
METHODS: Neurophysiological assessments (single motor-evoked potentials, corticospinal recruitment curves, short-interval intracortical inhibition, H-reflex) were performed in 14 adults with Tourette syndrome during voluntary tic inhibition and free ticcing. Regressions between behavioral performance and neurophysiological measures were also performed.
RESULTS: Voluntary tic inhibition reduced corticospinal excitability: the greater the ability to inhibit tics, the greater was the reduction in excitability. Voluntary tic inhibition was not associated with changes in the excitability of short-interval intracortical inhibition or the H-reflex.
CONCLUSIONS: Voluntary inhibition of tics reduces the excitability of corticospinal output. The pattern of neurophysiological findings is consistent with a withdrawal of excitation, but not with modulation of the inhibitory interneuronal mechanisms involved in short-interval intracortical inhibition.
© 2018 International Parkinson and Movement Disorder Society. © 2018 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  motor cortical excitability; tic disorders; transcranial magnetic stimulation; voluntary motor control; voluntary tic inhibition

Mesh:

Year:  2018        PMID: 30379360     DOI: 10.1002/mds.27479

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  8 in total

Review 1.  Towards real-world generalizability of a circuit for action-stopping.

Authors:  Ricci Hannah; Adam R Aron
Journal:  Nat Rev Neurosci       Date:  2021-07-29       Impact factor: 34.870

2.  Aberrant prefrontal cortical-striatal functional connectivity in children with primary complex motor stereotypies.

Authors:  Farhan Augustine; Mary B Nebel; Stewart H Mostofsky; E Mark Mahone; Harvey S Singer
Journal:  Cortex       Date:  2021-06-24       Impact factor: 4.644

3.  Impaired automatic but intact volitional inhibition in primary tic disorders.

Authors:  Vishal Rawji; Sachin Modi; Anna Latorre; Lorenzo Rocchi; Leanne Hockey; Kailash Bhatia; Eileen Joyce; John C Rothwell; Marjan Jahanshahi
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

Review 4.  Clinical Features That Evoke the Concept of Disinhibition in Tourette Syndrome.

Authors:  Lille Kurvits; Davide Martino; Christos Ganos
Journal:  Front Psychiatry       Date:  2020-02-25       Impact factor: 4.157

Review 5.  Contribution of TMS and TMS-EEG to the Understanding of Mechanisms Underlying Physiological Brain Aging.

Authors:  Andrea Guerra; Lorenzo Rocchi; Alberto Grego; Francesca Berardi; Concetta Luisi; Florinda Ferreri
Journal:  Brain Sci       Date:  2021-03-22

6.  Amplified engagement of prefrontal cortex during control of voluntary action in Tourette syndrome.

Authors:  Charlotte L Rae; Jim Parkinson; Sophie Betka; Cassandra D Gouldvan Praag; Samira Bouyagoub; Liliana Polyanska; Dennis E O Larsson; Neil A Harrison; Sarah N Garfinkel; Hugo D Critchley
Journal:  Brain Commun       Date:  2020-11-27

Review 7.  Non-invasive brain stimulation as therapy: systematic review and recommendations with a focus on the treatment of Tourette syndrome.

Authors:  Katherine Dyke; Georgina Jackson; Stephen Jackson
Journal:  Exp Brain Res       Date:  2021-10-13       Impact factor: 1.972

8.  Biomarkers Obtained by Transcranial Magnetic Stimulation in Neurodevelopmental Disorders.

Authors:  Ali Jannati; Mary A Ryan; Harper L Kaye; Melissa Tsuboyama; Alexander Rotenberg
Journal:  J Clin Neurophysiol       Date:  2022-02-01       Impact factor: 2.177

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.